NCT06798298View on ClinicalTrials.gov

A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

May 17, 2040

Study Completion Date

May 17, 2040

Conditions
Long Term Safety Following GM T Cell Therapy
Interventions
GENETIC

Non-interventional

No study drug administered. Long-term follow-up only.

Trial Locations (1)

37203

RECRUITING

Tennessee Oncology, Nashville

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY